Ginkgo Bioworks
PublicGinkgo Bioworks is now publicly traded
The data on this page reflects Ginkgo Bioworks's private-market history up to the point it went public, including its funding rounds, valuation, and investors.
Went Public
Sep 16, 2021
Last Round
Series E
Extension
May 28, 2020
Total Funding Raised
$2.42B
Company Overview
Ginkgo Bioworks is a biotechnology company that offers comprehensive cell programming solutions to address challenges in various sectors, including food, agriculture, pharmaceuticals, and industrial chemicals.
Sector
Biotech
AI Layer
Infrastructure
Keywords
Ginkgo Bioworks Comparables
Compare Ginkgo Bioworks with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Livzym Biotechnologies | 48% | |
| Growth Curve Bio, LLC | 47% | |
| Phytowelt GreenTechnologies GmbH | 46% |
Ginkgo Bioworks Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| IPO | Sep 16, 2021 | ||||
| Series E Extension | May 28, 2020 | ||||
| Series E | Sep 19, 2019 | ||||
| Series D | Dec 14, 2017 | ||||
| Series C | Jun 8, 2016 | ||||
Series B | Jul 23, 2015 |
Ginkgo Bioworks Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cascade Investment Group | Series C, Series D |
| Cascade Investment | Series C, Series D, IPO, Series E |
| Massachusetts Development Finance Agency | Series A |
| Allen & Company LLC | Series C |
| Bellco Capital | IPO |
| ArrowMark Partners | IPO |
| Collaborative Fund | Series A, Seed |
Ginkgo Bioworks Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access